235 related articles for article (PubMed ID: 24853998)
1. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.
Kanbay M; Solak Y; Unal HU; Kurt YG; Gok M; Cetinkaya H; Karaman M; Oguz Y; Eyileten T; Vural A; Covic A; Goldsmith D; Turak O; Yilmaz MI
Int Urol Nephrol; 2014 Aug; 46(8):1619-25. PubMed ID: 24853998
[TBL] [Abstract][Full Text] [Related]
2. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
[TBL] [Abstract][Full Text] [Related]
3. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.
Sonmez A; Yilmaz MI; Saglam M; Unal HU; Gok M; Cetinkaya H; Karaman M; Haymana C; Eyileten T; Oguz Y; Vural A; Rizzo M; Toth PP
Lipids Health Dis; 2015 Apr; 14():29. PubMed ID: 25885289
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
5. The predictive study of the relation between elevated low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and mortality in peritoneal dialysis.
Lin T; Xia X; Yu J; Qiu Y; Yi C; Lin J; Mao H; Yang X; Huang F
Lipids Health Dis; 2020 Mar; 19(1):51. PubMed ID: 32199459
[TBL] [Abstract][Full Text] [Related]
6. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
[TBL] [Abstract][Full Text] [Related]
7. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
[TBL] [Abstract][Full Text] [Related]
8. Cholesteryl ester transfer protein activity and cardiovascular events in patients with chronic kidney disease stage V.
Seiler S; Schlitt A; Jiang XC; Ulrich C; Blankenberg S; Lackner KJ; Girndt M; Werdan K; Buerke M; Fliser D; Heine GH
Nephrol Dial Transplant; 2008 Nov; 23(11):3599-604. PubMed ID: 18503096
[TBL] [Abstract][Full Text] [Related]
9. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
10. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.
Moradi H; Streja E; Kashyap ML; Vaziri ND; Fonarow GC; Kalantar-Zadeh K
Nephrol Dial Transplant; 2014 Aug; 29(8):1554-62. PubMed ID: 24574544
[TBL] [Abstract][Full Text] [Related]
11. HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.
Zewinger S; Speer T; Kleber ME; Scharnagl H; Woitas R; Lepper PM; Pfahler K; Seiler S; Heine GH; März W; Silbernagel G; Fliser D
J Am Soc Nephrol; 2014 May; 25(5):1073-82. PubMed ID: 24610925
[TBL] [Abstract][Full Text] [Related]
12. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
[TBL] [Abstract][Full Text] [Related]
13. Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
Echida Y; Ogawa T; Otsuka K; Ando Y; Nitta K
Clin Exp Nephrol; 2012 Oct; 16(5):767-72. PubMed ID: 22374049
[TBL] [Abstract][Full Text] [Related]
14. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD.
Lo JC; Go AS; Chandra M; Fan D; Kaysen GA
Am J Kidney Dis; 2007 Oct; 50(4):552-8. PubMed ID: 17900454
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
Nishizawa Y; Shoji T; Kakiya R; Tsujimoto Y; Tabata T; Ishimura E; Nakatani T; Miki T; Inaba M
Kidney Int Suppl; 2003 May; (84):S117-20. PubMed ID: 12694324
[TBL] [Abstract][Full Text] [Related]
16. The Predictive Role of Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio According to Renal Function in Patients with Acute Myocardial Infarction.
Kim JS; Kim W; Woo JS; Lee TW; Ihm CG; Kim YG; Moon JY; Lee SH; Jeong MH; Jeong KH;
PLoS One; 2016; 11(10):e0165484. PubMed ID: 27788233
[TBL] [Abstract][Full Text] [Related]
17. Visit-to-visit variability in estimated glomerular filtration rate predicts hospitalization and death due to cardiovascular events.
Suzuki A; Obi Y; Hayashi T; Kotani N; Uemura Y; Imai E; Makino H; Hishida A
Clin Exp Nephrol; 2019 May; 23(5):661-668. PubMed ID: 30687876
[TBL] [Abstract][Full Text] [Related]
18. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE
J Am Coll Cardiol; 2013 Oct; 62(17):1580-4. PubMed ID: 23916935
[TBL] [Abstract][Full Text] [Related]
19. Association between monocyte count to high-density lipoprotein cholesterol ratio and mortality in patients undergoing peritoneal dialysis.
Chen J; Zhong Z; Shi D; Li J; Li B; Zhang R; Zhang P; Huang N; Mao H; Li Z
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2081-2088. PubMed ID: 34039506
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
